Irofulven is an experimental alkylating agent under investigation as an active pharmaceutical ingredient. It is primarily studied for its potential in cancer research.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 158440-71-2
(11beta,20R)-11,17,20,21-Tetrahydroxypregna-1,4-dien-3-one
pharmaceutical raw material
2',6'-pipecoloxylidide
pharmaceutical raw material
Pralmorelin
pharmaceutical raw material
Montelukast
pharmaceutical raw material
(5'R)-5'-hydroxy-1'-(hydroxymethyl)-2',5',7'-trimethylspiro[cyclopropane-1,6'-indene]-4'-one
NICJCIQSJJKZAH-AWEZNQCLSA-N
CC1=C(C2=C(C3(CC3)[C@@](C(=O)C2=C1)(C)O)C)CO